» Articles » PMID: 29170841

Oxymatrine Induces Apoptosis and Inhibits Invasion in Gallbladder Carcinoma Via PTEN/PI3K/AKT Pathway

Overview
Journal Cytotechnology
Specialties Biotechnology
Genetics
Date 2017 Nov 25
PMID 29170841
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Oxymatrine extracted from Sophora flavescens Ait as a natural polyphenolic phytochemical has been demonstrated to exhibit anti-tumor effects on various cancers, including Gallbladder carcinoma (GBC). However, its underlying mechanisms of function are largely unknown in GBC cells. The present study is conducted to investigate the anti-tumor effects and the underlying mechanisms of oxymatrine on GBC cells in vitro and in vivo. The results showed that oxymatrine inhibited cell viability, metastatic ability and induced cell apoptosis in dose-dependent manners. Furthermore, we found that the expression of p-AKT, MMP-2, MMP-9 and the ratio of Bcl-2/Bax were significantly down-regulated, while the expression of PTEN was up-regulated in GBC cells. In addition, pretreatment with a specific PI3K/AKT activator (IGF-1) significantly antagonized the oxymatrine-mediated inhibition of GBC-SD cells. Subsequently, our in vivo studies showed that administration of oxymatrine induced a significant dose-dependent decrease in tumor growth. In conclusion, these findings indicated that the inhibition of cells proliferation, migration, invasion and the induction of apoptosis in response to oxymatrine in GBC cells, may function through the suppression of PTEN/PI3K/AKT pathway, which was considered as the vital signaling pathway in regulating tumorigenesis. These results suggested that oxymatrine might be a novel effective candidate as chemotherapeutic agent against GBC.

Citing Articles

The isolation and identification of Candida glabrata from avian species and a study of the antibacterial activities of Chinese herbal medicine in vitro.

Zhang S, Zhao Q, Xue W, Li Y, Guo Y, Wu X Poult Sci. 2021; 100(4):101003.

PMID: 33676095 PMC: 8046950. DOI: 10.1016/j.psj.2021.01.026.


Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer's Disease.

Chen S, Gao Y, Sun J, Meng X, Yang D, Fan L Front Pharmacol. 2020; 11:497.

PMID: 32390843 PMC: 7188934. DOI: 10.3389/fphar.2020.00497.


Oxymatrine Inhibits Proliferation and Migration of Vulvar Squamous Cell Carcinoma Cells via Attenuation of the RAS/RAF/MEK/ERK Pathway.

Wang Y, Yang S, Zhang S, Wu X Cancer Manag Res. 2020; 12:2057-2067.

PMID: 32256113 PMC: 7090165. DOI: 10.2147/CMAR.S245696.


Oxymatrine inhibits the migration and invasion of hepatocellular carcinoma cells by reducing the activity of MMP-2/-9 via regulating p38 signaling pathway.

Chen K, Zhu P, Ye J, Liao Y, Du Z, Chen F J Cancer. 2019; 10(22):5397-5403.

PMID: 31632484 PMC: 6775708. DOI: 10.7150/jca.32875.


Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology.

Meng Z, Liu X, Wu J, Zhou W, Wang K, Jing Z Evid Based Complement Alternat Med. 2019; 2019:4637839.

PMID: 31275410 PMC: 6558614. DOI: 10.1155/2019/4637839.


References
1.
Song M, Zhu J, Chen J, Wang L, Da W, Zhu L . Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells. World J Gastroenterol. 2007; 13(12):1788-93. PMC: 4149953. DOI: 10.3748/wjg.v13.i12.1788. View

2.
Orrenius S . Mitochondrial regulation of apoptotic cell death. Toxicol Lett. 2004; 149(1-3):19-23. DOI: 10.1016/j.toxlet.2003.12.017. View

3.
Chen H, Zhang J, Luo J, Lai F, Wang Z, Tong H . Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway. Oncol Rep. 2013; 30(2):589-95. DOI: 10.3892/or.2013.2529. View

4.
Cao Y, Jing S, Li L, Gao J, Shen Z, Liu Y . Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens. Phytother Res. 2010; 24(12):1844-9. DOI: 10.1002/ptr.3206. View

5.
Abahssain H, Afchain P, Melas N, Ismaili N, Rahali R, Rabti H . [Chemotherapy in gallbladder carcinoma]. Presse Med. 2010; 39(12):1238-45. DOI: 10.1016/j.lpm.2010.09.002. View